ODI Pharma AB announces strategic market entry with initial shipment to Switzerland
ODI Pharma AB (“ODI” or the “Company”) is pleased to announce the first delivery of cannabis products to the leading medical cannabis provider in Switzerland. The delivery marks a symbolic milestone in ODI's market expansion efforts as it is the first delivery to the Swiss market. The delivery, which is facilitated through ODI’s Swiss subsidiary, is less significant in terms of economic value but more important from a strategic point of view.Exploration of Other European Markets ODI Pharma is consolidating its position in the Eastern European medical cannabis market and is exploring